358 related articles for article (PubMed ID: 3756927)
21. Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar': preference for lung and heart DNA.
Randerath E; Mittal D; Randerath K
Carcinogenesis; 1988 Jan; 9(1):75-80. PubMed ID: 2826034
[TBL] [Abstract][Full Text] [Related]
22. Monitoring tobacco smoke-induced DNA damage by 32P-postlabelling.
Randerath E; Randerath K
IARC Sci Publ; 1993; (124):305-14. PubMed ID: 8225499
[TBL] [Abstract][Full Text] [Related]
23. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
Gupta RC
Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
[TBL] [Abstract][Full Text] [Related]
24. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
Jones NJ; McGregor AD; Waters R
Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
[TBL] [Abstract][Full Text] [Related]
25. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
Eder E; Schuler D; Budiawan
IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
[TBL] [Abstract][Full Text] [Related]
26. A comparison of DNA adduct formation in white blood cells and internal organs of mice exposed to benzo[a]pyrene, dibenzo[c,g]carbazole, safrole and cigarette smoke condensate.
Reddy MV; Randerath K
Mutat Res; 1990 May; 241(1):37-48. PubMed ID: 2333084
[TBL] [Abstract][Full Text] [Related]
27. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
29. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis.
Wang M; Abbruzzese JL; Friess H; Hittelman WN; Evans DB; Abbruzzese MC; Chiao P; Li D
Cancer Res; 1998 Jan; 58(1):38-41. PubMed ID: 9426054
[TBL] [Abstract][Full Text] [Related]
30. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.
Arif JM; Dresler C; Clapper ML; Gairola CG; Srinivasan C; Lubet RA; Gupta RC
Chem Res Toxicol; 2006 Feb; 19(2):295-9. PubMed ID: 16485906
[TBL] [Abstract][Full Text] [Related]
31. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
Randerath K; Miller RH; Mittal D; Randerath E
IARC Sci Publ; 1988; (89):361-7. PubMed ID: 3198221
[TBL] [Abstract][Full Text] [Related]
32. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung.
Wiencke JK; Kelsey KT; Varkonyi A; Semey K; Wain JC; Mark E; Christiani DC
Cancer Res; 1995 Nov; 55(21):4910-4. PubMed ID: 7585529
[TBL] [Abstract][Full Text] [Related]
33. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from coke oven workers: correlation with job categories.
Ovrebø S; Haugen A; Phillips DH; Hewer A
Cancer Res; 1992 Mar; 52(6):1510-4. PubMed ID: 1540959
[TBL] [Abstract][Full Text] [Related]
34. 32P-postlabeling analysis of aromatic DNA adducts in fish from polluted areas.
Dunn BP; Black JJ; Maccubbin A
Cancer Res; 1987 Dec; 47(24 Pt 1):6543-8. PubMed ID: 3677092
[TBL] [Abstract][Full Text] [Related]
35. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay.
Randerath E; Miller RH; Mittal D; Avitts TA; Dunsford HA; Randerath K
J Natl Cancer Inst; 1989 Mar; 81(5):341-7. PubMed ID: 2915370
[TBL] [Abstract][Full Text] [Related]
36. Detection of DNA damage derived from a direct acting ethylating agent present in cigarette smoke by use of liquid chromatography-tandem mass spectrometry.
Singh R; Kaur B; Farmer PB
Chem Res Toxicol; 2005 Feb; 18(2):249-56. PubMed ID: 15720129
[TBL] [Abstract][Full Text] [Related]
37. Carcinogen-DNA adducts in human breast tissue.
Perera FP; Estabrook A; Hewer A; Channing K; Rundle A; Mooney LA; Whyatt R; Phillips DH
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):233-8. PubMed ID: 7606197
[TBL] [Abstract][Full Text] [Related]
38. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
Randerath K; Randerath E; Agrawal HP; Reddy MV
IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
[TBL] [Abstract][Full Text] [Related]
39. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
Funk D; Sorg BL; Lindner SC; Schmeiser HH
Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
[TBL] [Abstract][Full Text] [Related]
40. Oxidative DNA adducts detected in vitro from redox activity of cigarette smoke constituents.
Vadhanam MV; Thaiparambil J; Gairola CG; Gupta RC
Chem Res Toxicol; 2012 Nov; 25(11):2499-504. PubMed ID: 22994544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
